Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Sales (2016 - 2026)

Ekso Bionics Holdings has reported Return on Sales over the past 13 years, most recently at 1.49% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 104.0% to 1.49% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.07%, a 47.0% decrease, with the full-year FY2025 number at 1.07%, down 47.0% from a year prior.
  • Return on Sales reached 1.49% in Q4 2025 per EKSO's latest filing, down from 0.34% in the prior quarter.
  • The five-year high for Return on Sales was 0.34% in Q3 2025, with the low at 1.96% in Q2 2025.
  • The 5-year median for Return on Sales is 1.01% (2025), against an average of 1.05%.
  • Peak YoY movement for Return on Sales: skyrocketed 164bps in 2021, then plummeted -148bps in 2025.
  • Tracing EKSO's Return on Sales over 5 years: stood at 1.13% in 2021, then decreased by -13bps to 1.27% in 2022, then surged by 43bps to 0.73% in 2023, then soared by 38bps to 0.45% in 2024, then tumbled by -230bps to 1.49% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.49%, 0.34%, and 1.96% for Q4 2025, Q3 2025, and Q2 2025 respectively.